NorthCrest Asset Manangement’s AbbVie ABBV Stock Holding History

NorthCrest Asset Manangement’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$600K	Buy	+2,400	New	+$516K	0.02%	509
2024 Q4	–	Sell	-2,500	Closed	-$4.82K	–	564
2024 Q3	$4.82K	Buy	2,500 +2,449	+4,802%	+$457K	﹤0.01%	551
2024 Q2	$145K	Sell	51 -749	-94%	-$124K	﹤0.01%	503
2024 Q1	$224	Hold	800	–	–	﹤0.01%	507
2023 Q4	$1.52K	Sell	800 -1,700	-68%	-$248K	﹤0.01%	512
2023 Q3	$11.2K	Buy	+2,500	New	+$367K	﹤0.01%	498
2023 Q2	–	Sell	-2,500	Closed	-$1.68K	–	499
2023 Q1	$1.68K	Buy	+2,500	New	+$382K	﹤0.01%	486

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

CRM

Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NorthCrest Asset Manangement's ABBV Position: Q2 2026 in Review

NorthCrest Asset Manangement increased its AbbVie (ABBV) stake by 4.2% in Q2 2026, buying an estimated $874K and bringing the position to 100,564 shares worth $25.1M. The position accounts for 0.65% of the portfolio, ranked #30.

NorthCrest Asset Manangement first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $31.1M in Q3 2025. 803 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

NorthCrest Asset Manangement held 100,564 shares of AbbVie worth $25.1M as of Q2 2026.
NorthCrest Asset Manangement bought 4,064 AbbVie shares in Q2 2026, an estimated $874K.
AbbVie made up 0.65% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #30 holding.
NorthCrest Asset Manangement first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
NorthCrest Asset Manangement's AbbVie position peaked at $31.1M in Q3 2025.
803 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.